Clinical trial
Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related…
NCT00102115 · Light Sciences LLC, Industry · Terminated
Key facts
| NCT number | NCT00102115 |
|---|---|
| Title | Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease |
| Official title | Phase 1 Dose Ranging Study to Evaluate Safety and Tolerability of Talaporfin Sodium (LS11) Photodynamic Therapy in Subjects With Advanced Age-Related Macular Disease |
| Lead sponsor | Light Sciences LLC, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Choroidal Neovascularization |
| Intervention type | Drug |
| Interventions | Talaporfin Sodium (LS11) Photodynamic Therapy (PDT) |
| Enrollment | 27 |
| Start date | Dec 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Jan 24, 2005 |
| Last update posted | Mar 12, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: